Stay updated on Oral AT2101 in Gaucher Disease Clinical Trial
Sign up to get notified when there's something new on the Oral AT2101 in Gaucher Disease Clinical Trial page.

Latest updates to the Oral AT2101 in Gaucher Disease Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the afegostat tartrate study in treatment-naive patients with type 1 Gaucher disease is available, showing its study details and posted results information.SummaryDifference47%

- Check11 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a standard error page. This indicates the record cannot be accessed at this time.SummaryDifference17%

Stay in the know with updates to Oral AT2101 in Gaucher Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral AT2101 in Gaucher Disease Clinical Trial page.